Banyan Biomarkers Inc - Product Pipeline Analysis, 2018 Update

Banyan Biomarkers Inc - Product Pipeline Analysis, 2018 Update


  • Products Id :- GDME16187PD
  • |
  • Pages: 35
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Banyan Biomarkers Inc (Banyan Biomarkers) is a medical technology company that commercializes vitro diagnostic tests for the detection of traumatic brain injury and neurological diseases. The company's product pipeline includes biomarkers for depression, hypoxic ischemic encephalopathy, neuro ICU monitoring, sub acute or chronic traumatic brain injury, and stroke. Its biomarker includes cellular components, proteins, and physiologic or imaging findings that relate to a disease or injury. Banyan Biomarkers products are tested using enzyme-linked immunosorbent assay's. The company also provides a point of care diagnostic blood test to detect the presence of mild and moderate brain trauma of head injured patients. It operates in California and Florida. Banyan Biomarkers is headquartered in Alachua, Florida, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Banyan Biomarkers Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Banyan Biomarkers Inc Company Overview 5

Banyan Biomarkers Inc Company Snapshot 5

Banyan Biomarkers Inc Pipeline Products and Ongoing Clinical Trials Overview 5

Banyan Biomarkers Inc-Pipeline Analysis Overview 8

Banyan Biomarkers Inc-Key Facts 8

Banyan Biomarkers Inc-Major Products and Services 9

Banyan Biomarkers Inc Pipeline Products by Development Stage 10

Banyan Biomarkers Inc Pipeline Products Overview 12

Banyan UCH-L1/GFAP Detection Assay 12

Banyan UCH-L1/GFAP Detection Assay Product Overview 12

Diagnostic Assay-Alcoholism 13

Diagnostic Assay-Alcoholism Product Overview 13

Diagnostic Assay-Alzheimer's Disease 14

Diagnostic Assay-Alzheimer's Disease Product Overview 14

Diagnostic Assay-Amyotrophic Lateral Sclerosis 15

Diagnostic Assay-Amyotrophic Lateral Sclerosis Product Overview 15

Diagnostic Assay-Depression 16

Diagnostic Assay-Depression Product Overview 16

Diagnostic Assay-Huntington's Disease 17

Diagnostic Assay-Huntington's Disease Product Overview 17

Diagnostic Assay-Hypoxic Ischemic Encephalopathy 18

Diagnostic Assay-Hypoxic Ischemic Encephalopathy Product Overview 18

Diagnostic Assay-Neuro ICU Monitoring 19

Diagnostic Assay-Neuro ICU Monitoring Product Overview 19

Diagnostic Assay-Parkinson's Disease 20

Diagnostic Assay-Parkinson's Disease Product Overview 20

Diagnostic Assay-Seizure 21

Diagnostic Assay-Seizure Product Overview 21

Diagnostic Assay-Stroke 22

Diagnostic Assay-Stroke Product Overview 22

Diagnostic Test-Shaken Baby Syndrome (SBS) 23

Diagnostic Test-Shaken Baby Syndrome (SBS) Product Overview 23

Banyan Biomarkers Inc-Key Competitors 24

Banyan Biomarkers Inc-Key Employees 25

Banyan Biomarkers Inc-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Recent Developments 27

Banyan Biomarkers Inc, Recent Developments 27

Feb 19, 2018: Penthrox : First order received for Austria 27

Feb 14, 2018: FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults 27

Feb 12, 2018: DarioHealth Partners with a Leading Diabetes Clinic 28

Mar 06, 2017: Herb Boyer, PhD and Frederic Sweeney, PhD Join Banyan Biomarkers' Board of Directors 28

Nov 05, 2015: Banyan Biomarkers Reports Successful Clinical Trial Results of Blood Test to Evaluate Mild and Moderate Traumatic Brain Injury 29

Jul 23, 2015: Banyan Biomarkers Selected as Final Winner of GE and NFL Head Health Challenge I 29

May 09, 2012: Banyan Biomarkers Announces That Andrew Von Eschenbach Joins the Board of Directors 30

Feb 21, 2012: Banyan Biomarkers Announces That Henry L. Nordhoff Joins the Board of Directors as Executive Chairman 31

Aug 04, 2011: Banyan Works With Emory University To Analyze Biomarkers In Clinical Trial Of Progesterone In TBI 31

Oct 05, 2010: Banyan Biomarkers Receives USD 26.3 Million Contract To Develop Diagnostic Test For TBI 31

Appendix 32

Methodology 32

About GlobalData 35

Contact Us 35

Disclaimer 35

List of Figures

Banyan Biomarkers Inc Pipeline Products by Equipment Type 6

Banyan Biomarkers Inc Pipeline Products by Development Stage 10

List of Tables

Banyan Biomarkers Inc Pipeline Products and Ongoing Clinical Trials Overview 5

Banyan Biomarkers Inc Pipeline Products by Equipment Type 6

Banyan Biomarkers Inc Pipeline Products by Indication 7

Banyan Biomarkers Inc, Key Facts 8

Banyan Biomarkers Inc, Major Products and Services 9

Banyan Biomarkers Inc Number of Pipeline Products by Development Stage 10

Banyan Biomarkers Inc Pipeline Products Summary by Development Stage 11

Banyan UCH-L1/GFAP Detection Assay-Product Status 12

Banyan UCH-L1/GFAP Detection Assay-Product Description 12

Diagnostic Assay-Alcoholism-Product Status 13

Diagnostic Assay-Alcoholism-Product Description 13

Diagnostic Assay-Alzheimer's Disease-Product Status 14

Diagnostic Assay-Alzheimer's Disease-Product Description 14

Diagnostic Assay-Amyotrophic Lateral Sclerosis-Product Status 15

Diagnostic Assay-Amyotrophic Lateral Sclerosis-Product Description 15

Diagnostic Assay-Depression-Product Status 16

Diagnostic Assay-Depression-Product Description 16

Diagnostic Assay-Huntington's Disease-Product Status 17

Diagnostic Assay-Huntington's Disease-Product Description 17

Diagnostic Assay-Hypoxic Ischemic Encephalopathy-Product Status 18

Diagnostic Assay-Hypoxic Ischemic Encephalopathy-Product Description 18

Diagnostic Assay-Neuro ICU Monitoring-Product Status 19

Diagnostic Assay-Neuro ICU Monitoring-Product Description 19

Diagnostic Assay-Parkinson's Disease-Product Status 20

Diagnostic Assay-Parkinson's Disease-Product Description 20

Diagnostic Assay-Seizure-Product Status 21

Diagnostic Assay-Seizure-Product Description 21

Diagnostic Assay-Stroke-Product Status 22

Diagnostic Assay-Stroke-Product Description 22

Diagnostic Test-Shaken Baby Syndrome (SBS)-Product Status 23

Diagnostic Test-Shaken Baby Syndrome (SBS)-Product Description 23

Banyan Biomarkers Inc, Key Employees 25

Banyan Biomarkers Inc, Other Locations 26

Glossary 34

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Population Bio Inc

Exagen Diagnostics Inc

Stemina Biomarker Discovery Inc

Integrated Diagnostics Inc

Beacon Sciences LLC

Banyan Biomarkers Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 53925
Site License
USD 1,500 INR 72
Corporate User License
USD 2,250 INR 144

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com